Endometriosis
Conditions
Keywords
endometriosis, diet, inflammation, chronic pelvic pain
Brief summary
The study aims to investigate the nutritional status and eating habits of women suffering from endometriosis and chronic pelvic pain in relation to describe the possible improvement of clinical symptoms following a nutritional intervention. The primary aim is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain. The first secondary aim will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some specific areas of the patients (sexual, psychological) together with the quantification of some routine blood chemistry parameters (inflammatory markers, levels of proteins and vitamins) . The second secondary objective will be aimed at describing the changes in clinical symptoms and the parameters mentioned above in patients based on the severity/stage of the pathologies under study.
Interventions
The nutritional intervention will consist in providing general nutritional indications specific for endometriosis and an indicative ungrammatical daily diet plan, which must be followed for the entire period of intervention (6 months).
Sponsors
Study design
Eligibility
Inclusion criteria
* Clinical diagnosis of endometriosis +/- chronic pelvic pain * No menopause (at least 1 menstrual cycle in the previous 6 months) * Informed consent from the patient and / or an authorized legal representative
Exclusion criteria
* Postmenopause * Pregnancy * Hysterectomy or oophorectomy * Chronic diseases that affect the gastrointestinal absorption of nutrients (celiac disease, Chron's disease, ulcerative colitis, cystic fibrosis) * History of kidney stones, cancer (except basal cell carcinoma) or diabetes * Modification in the course of the therapeutic intervention of the therapy for endometriosis
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (pain, quality of life and intestinal function) in women suffering from endometriosis with chronic pelvic pain. | 6 months | The outcome will be assessed with repeated measurements using the following parameters: -Evaluation of chronic pelvic pain, dysmenorrhea, dyschezia and dysuria: VAS visual analogue scale, from 0 to 10 points where 10 points indicates worst pain |
| The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (quality of life) in women suffering from endometriosis with chronic pelvic pain. | 6 months | The outcome will be assessed with repeated measurements using the following parameters: Quality of life: measurement of physical and mental components with SF36 consisting of two components, one physical and one mental. Both fall within a range from 0 to 100 points where higher values are associated with better health |
| The primary outcome is to describe and evaluate the impact of nutritional intervention on clinical symptoms (intestinal function) in women suffering from endometriosis with chronic pelvic pain. | 6 months | The outcome will be assessed with repeated measurements using the following parameters: Bowel Function: Knowles-Eccersley-Scott Symptom Questionnaire (KESS) (points) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following questionnaires: Alexithymia Scale (TAS) questionnaire (points) |
| The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some routine blood chemistry parameters | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following routine blood chemistry parameters: Measure Ca125 (unità/ml) and Vitamin D (ng/ml) |
| The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Sexual Function | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire: Sexual Function: FSFI questionnaire (points) |
| The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in some Inflammatory markers | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following Inflammatory markers: IL-6 and IL-1β values (pg/ml) |
| The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in measurement of proteins | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following measurement of proteins: C-reactive protein values (mg/dL) |
| The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Intestinal inflammatory marker | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following test: fecal calprotectin (mg/kg) |
| To describe and evaluate the impact of the nutritional intervention by describing the changes in Urinary function and bladder pain | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire: Urinary function and bladder pain: PUF and O's Leary / Sant questionnaire (points) |
| The secondary outcome will be to describe and evaluate the impact of the nutritional intervention by describing the changes in Psychological component about Depression | 6 months | The outcomes necessary to respond to the secondary objective are the administration of the following questionnaire: Beck Depression Inventory (BDI) (points) |
Countries
Italy